BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 14, 2019
View Archived Issues
Metformin rejuvenates stem cells, restores CNS remyelination
Read More
Enrollment begins in first-in-human study of REGN-5459
Read More
Libella Gene Therapeutics initiates phase I study of its AAV-hTERT gene therapy
Read More
Phase II RESIST study of MAP-4343 begins in patients with drug-resistant depression
Read More
Novartis presents data from ASCEND-7 phase II study of ceritinib
Read More
ABCC3 as a novel pharmacological target in pancreatic cancer
Read More
New insulin receptor partial agonists discovered at Merck & Co.
Read More
Emory University discloses CXCR-4 and/or CCR5 antagonists
Read More
Well Marker Bio describes new macrophage-stimulating protein receptor inhibitors
Read More
[177Lu]PSMA-R2 shows strong antitumor activity in prostate cancer xenograft model
Read More
Better late than never for schizophrenia gene targeting
Read More
Mitochondrial mutations hamper nuclear DNA repair
Read More
Novel phenylpropanoid analogue promotes neurogenesis, ameliorates cognitive impairment in AD models
Read More
Evaluating the role of UCK2 as a biomarker for patient selection for RX-3117 treatment
Read More
Synblia Therapeutics patents PTPN11 inhibitors
Read More
Dual IDO-1/TDO inhibitors presented by CHA Health Systems and CMG Pharmaceutical
Read More
RedHill reports full data from phase III MAP US study of RHB-104 in Crohn's disease
Read More
FDA approves Reyvow for acute treatment of migraine
Read More
RegenxBio presents phase I/IIa interim data on RGX-314 in wet AMD
Read More
Eyevensys provides initial data from phase I/II study of EYS-606 for noninfectious uveitis
Read More
Auris reports phase Ib interim data on AM-201 for antipsychotic-induced weight gain and somnolence
Read More
Kodiak reports phase Ib data on KSI-301 in wet AMD, DME and RVO
Read More
[68Ga]FAPI-04 imaging evaluated in studies in cancer patients
Read More
ReNeuron announces phase I/IIa data on hRPC stem cell therapy in retinitis pigmentosa
Read More